Allakos halves workforce, drops lead inflammatory program
California biotech Allakos said it would end development of its lead inflammatory disease program and lay off half of its workforce to save costs. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
